Related Experiment Video
Updated: Sep 26, 2025

Use of the Soft-agar Overlay Technique to Screen for Bacterially Produced Inhibitory Compounds
Published on: January 14, 2017
Interbacterial Antagonism Mediated by a Released Polysaccharide
Yiwei Liu1,2, Erin S Gloag2, Preston J Hill2
1Department of Microbiology, Ohio State University, Columbus, Ohio, USA.
Abstract:
Pseudomonas aeruginosa and Staphylococcus aureus are two common pathogens causing chronic infections in the lungs of people with cystic fibrosis (CF) and in wounds, suggesting that these two organisms coexist in vivo. However, P. aeruginosa utilizes various mechanisms to antagonize S. aureus when these organisms are grown together in vitro. Here, we suggest a novel role for Psl in antagonizing S. aureus growth. Psl is an exopolysaccharide that exists in both cell-associated and cell-free forms and is important for biofilm formation in P. aeruginosa. When grown in planktonic coculture with a P. aeruginosa psl mutant, S. aureus had increased survival compared to when it was grown with wild-type P. aeruginosa. We found that cell-free Psl was critical for the killing, as purified cell-free Psl was sufficient to kill S. aureus. Transmission electron microscopy of S. aureus treated with Psl revealed disrupted cell envelopes, suggesting that Psl causes S. aureus cell lysis. This was independent of known mechanisms used by P. aeruginosa to antagonize S. aureus. Cell-free Psl could also promote S. aureus killing during growth in in vivo-like conditions. We also found that Psl production in P. aeruginosa CF clinical isolates positively correlated with the ability to kill S. aureus. This could be a result of P. aeruginosa coevolution with S. aureus in CF lungs. In conclusion, this study defines a novel role for P. aeruginosa Psl in killing S. aureus, potentially impacting the coexistence of these two opportunistic pathogens in vivo. IMPORTANCE Pseudomonas aeruginosa and Staphylococcus aureus are two important opportunistic human pathogens commonly coisolated from clinical samples. However, P. aeruginosa can utilize various mechanisms to antagonize S. aureus in vitro. Here, we investigated the interactions between these two organisms and report a novel role for P. aeruginosa exopolysaccharide Psl in killing S. aureus. We found that cell-free Psl could kill S. aureus in vitro, possibly by inducing cell lysis. This was also observed in conditions reflective of in vivo scenarios. In accord with this, Psl production in P. aeruginosa clinical isolates positively correlated with their ability to kill S. aureus. Together, our data suggest a role for Psl in affecting the coexistence of P. aeruginosa and S. aureus in vivo.
Insights
Pseudomonas aeruginosa exopolysaccharide Psl kills Staphylococcus aureus by causing cell lysis, impacting pathogen coexistence in cystic fibrosis lungs and wounds. Psl production in clinical isolates correlates with S. aureus killing ability.
Area of Science:
- Microbiology
- Pathogen Interactions
- Biochemistry
Background:
- Pseudomonas aeruginosa and Staphylococcus aureus are common pathogens in cystic fibrosis and wound infections.
- These bacteria often coexist in vivo, despite P. aeruginosa's known in vitro antagonism mechanisms.
- The role of P. aeruginosa's exopolysaccharide Psl in this interaction was previously unclear.
Purpose of the Study:
- To investigate the novel role of Psl in antagonizing Staphylococcus aureus growth.
- To determine if Psl contributes to the killing of S. aureus by P. aeruginosa.
- To explore the implications of Psl-mediated antagonism for pathogen coexistence.
Main Methods:
- Coculture experiments comparing wild-type P. aeruginosa with a psl mutant against S. aureus.
- Purification and application of cell-free Psl to S. aureus.
- Transmission electron microscopy to observe S. aureus cell envelope integrity.
- Testing Psl's killing activity under in vivo-like conditions.
- Correlation analysis of Psl production and S. aureus killing in clinical isolates.
Main Results:
- S. aureus survival was higher when grown with a P. aeruginosa psl mutant compared to wild-type.
- Purified cell-free Psl was sufficient to kill S. aureus.
- Psl treatment resulted in disrupted S. aureus cell envelopes, indicating cell lysis.
- Psl-mediated killing of S. aureus was observed under in vivo-like conditions.
- Psl production in clinical P. aeruginosa isolates positively correlated with their ability to kill S. aureus.
Conclusions:
- Pseudomonas aeruginosa Psl plays a novel role in killing Staphylococcus aureus, independent of known antagonism mechanisms.
- Cell-free Psl induces S. aureus cell lysis, affecting pathogen interactions.
- Psl-mediated antagonism may influence the coexistence of P. aeruginosa and S. aureus in clinical settings like cystic fibrosis lungs.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Signaling
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Formation of Lipopolysaccharides
Biofilms

